Latest Tuberculosis treatment Stories
SAN FRANCISCO, Oct.
Genzyme, a biotechnology company, has started enrollment in a world-wide post-marketing clinical trial evaluating the efficacy and safety of treating pediatric male patients with mild Fabry disease symptoms with a low-dose regimen of Fabrazyme.
ORLANDO, Fla., Oct. 6 /PRNewswire/ -- UCB today presented data from a large, prospective study investigating endoscopic improvement in Crohn's disease (CD) with a biologic compound.
U.S. researchers have determined that Mycobacterium tuberculosis has learned through evolution to coat itself with a sugar called mannose. This sugar makes the bacterium attractive to cells in the lungs that are looking to clean up and discard unwanted sugar in the body.
By John Canalis LONG BEACH - A single case of tuberculosis has been confirmed at Wilson High School, city health officials said Friday. Authorities would not identify the victim or say if the infected party was a student, teacher, staff member or volunteer.
By HILL, Ruth HEALTH officials have broadened their search for people who may have been infected by a rare, aggressive form of tuberculosis that killed an Auckland woman before it was diagnosed.
Health officials in New Zealand are looking for anyone who may have been exposed to a woman with an aggressive form of tuberculosis.
By Graeme Hetherington A DOCTOR is working with HIV and TB patients in the remote heart of Africa with the support of a North-East charity.
LEUVEN, Belgium, August 28 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its financial results for the six month period ending June 30, 2008.
By Aggarwal, Deepak Mohapatra, P R; Rekha, V V Banu; Balasubramanian, R; Swaminathan, S; Ramachandran, R; Rahman, F; Sundaram, V; Thyagarajan, K; Selvakumar, N; Adhilakshmi, A R; Iliayas, S; Narayanan, P R Sir, Banu Rekha and colleagues' in their study found that at the end of intensive phase of tuberculosis treatment among sputum positive cases, the smear conversion rates were 58, 61, 62 per cent and culture conversion 86, 88 and 92 per cent respectively.
- a slit in a tire to drain away surface water and improve traction.